News items related to:
-
Pan-genotypic Hep-C drug added to Thai health system
The first pan-genotypic Hepatitis C drug, which can be prescribed without the requirement for expensive and limited testing to determine...
-
Activism is “keeping your feet on the ground”
Interviewed by Gemma Taylor. “I am from a traditional family in Manipur. The way we were brought up was to...
-
Getting India’s struggling Hep-C services re-open during COVID-19
For the estimated 6-12 million people living with Hepatitis C in India, access to treatment was already way below the...
-
Russian government issues its first health-related compulsory license
A new year signals a new approach to access to medicines in the Russian Federation. Remdesivir, a drug patented by...
-
New data demonstrates the impact of patents in Ukraine
2020 will be remembered for COVID-19. The scale of the pandemic highlights the urgent need to ensure equitable access to...
-
Natalia: “You only live once (YOLO), make it positive!”
An interview with Natalia, a former team member and friend of 100% LIFE, our campaign partner in Ukraine, and life-long...
-
A Tribute: Dr. Mongkol Na Songkhla – Putting Health Before Trade
We join our partner in Thailand, and activists around the world, to pay tribute to Dr. Mongkol Na Songkhla, a...
-
Thailand submits patent opposition on TB drug for children
Johnson & Johnson’s TB drug, bedaquiline (BDQ) can improve lives. The pediatric version is not substantially different to the adult...
-
“Training the next generation of treatment activists in Central America”
“Only around half of people living with HIV across Central America have access to life-saving treatment. The picture when it...
-
Vietnam’s route to optimal, affordable HIV treatment
Following civil society advice, Vietnam’s Ministry of Health recommended TLD for HIV treatment. This was back in November 2019. Vietnam...
-
OPINION: Breaking a ‘vicious cycle’ of overpaying for HIV drugs in Ukraine
“In November 2020, Ukraine finally shifted from the overpriced branded version of darunavir (DRV) to the more affordable generic version of...
-
HIV activists are essential to the COVID-19 response
The legacy of HIV activism is approaching a 40-year history, one which is inextricably linked with the actions of pharmaceutical...